Dr. Baizer is a Program Director in the National Center for Sleep Disorders Research (NCSDR) in the National Heart, Lung and Blood Institute (NHLBI) where he manages extramural research projects in disorders of sleep and circadian rhythms. More recent efforts at NHLBI include investigation of the epidemiology and pathophysiology of the long-term effects of Covid 19. He was previously at the Coordinating Center for Clinical Trials in the Office of the Director, National Cancer Institute (NCI), where he managed reviews of clinical trials in both adult and pediatric hematologic malignancies. At the NCI he also collaborated in funding correlative science projects through the Biomarkers, Imaging and Quality of Life Studies Funding Program (BIQSFP). Prior to joining the NCI, Dr. Baizer was a Program Officer in the Institute on Alcohol Abuse and Alcoholism (NIAAA), where his portfolio included investigations of the effects of alcohol abuse on adolescent brain development and sleep. While at the NIAAA, he developed an FOA on Alcohol Abuse, Sleep Disorders and Circadian Rhythms. He also contributed to the OppNet FOA on Sleep and the Social Environment and was a member of the Trans-NIH Sleep Research Coordinating Committee. Before coming to the NIH, Dr. Baizer was an investigator at the Neurological Sciences Institute of Oregon Health and Sciences University, where his laboratory pursued NIH-funded investigations of molecular and genetic mechanisms of neuronal development. He received a PhD in Pharmacology from the University of Colorado Health Sciences Center and completed post-doctoral studies at Harvard Medical School.
